Evidence map›Paper›PMID 41328149›Full record

ArticleCureus2025

Biopsy-Confirmed Cerebral Amyloid Angiopathy-Related Inflammation With Absence of Cerebral Microbleeds on T2* and Detectable Only by Susceptibility-Weighted Imaging.

Takeshi Araki, Hisatsugu Tachibana, Yoshihiro Ikura, Tatsuo Matsushita

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takeshi ArakiNeurology, Takatsuki General Hospital, Osaka, JPN.
Hisatsugu TachibanaNeurology, Takatsuki General Hospital, Osaka, JPN.
Yoshihiro IkuraPathology, Takatsuki General Hospital, Osaka, JPN.
Tatsuo MatsushitaNeurology, Takatsuki General Hospital, Osaka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare but treatable inflammatory condition in which there is amyloid-beta deposition in cortical and leptomeningeal vessels. Patients with CAA-ri often present with a high number of cerebral microbleeds (CMBs). Susceptibility-weighted imaging (SWI) is more sensitive than T2* for detecting these CMBs. However, SWI is not currently mandatory for the diagnosis of CAA-ri. Here, we present the case of an 82-year-old man with worsening confusion and bilateral visual loss. MRI revealed no CMBs on T2*, but a small number were detected using thin-slice SWI. Histopathology confirmed Aβ-related angiitis with inflammation and amyloid deposits in the vascular media. Steroid treatment improved clinical outcomes, but mild CMBs and increased cortical superficial siderosis were detected on follow-up MRI. As shown in this case, assessment of CAA-ri requires thorough evaluation of CMBs using SWI because T2* alone may be insufficient. If significant CMBs are minimal, leptomeningeal enhancement may indicate the need for biopsy for early diagnosis.

Indexed as

amyloid-beta-related angiitiscerebral amyloid angiopathy-related inflammationcerebral microbleedsleptomeningeal enhancementsusceptibility-weighted imaging

Identifiers

PMID41328149
PMCPMC12665156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.